Tom Brady-backed telehealth firm eMed valued at over $2 billion in latest funding round

Telehealth firm eMed said on Thursday it has raised $200 million in its latest funding round, valuing the Miami, Florida-based company at more than $2 billion. Backed by seven-time Super Bowl champion Tom Brady, the company partners with employers and government payers ‌to manage ⁠GLP-1 usage, a ⁠class of obesity and diabetes drugs whose cost burden has been a barrier to wider insurance coverage. Several telehealth platforms are competing for a slice of the booming GLP-1 weight-loss market, widely expected to generate $150 billion in annual sales by next decade.